Why the study?
Does AT1 receptor antagonism with ZD7155 improve alveolar fluid clearance in rats with LPS-induced acute lung injury?
Does AT1 receptor antagonism with ZD7155 improve alveolar fluid clearance in rats with LPS-induced acute lung injury?
Endogenous Angiotensin II inhibits alveolar fluid clearance via AT1 receptors in LPS-induced acute lung injury, suggesting AT1 antagonism may reduce pulmonary edema.
AT1 antagonism may enhance fluid clearance in experimental ALI; leaves open translation to human pulmonary edema.
BACKGROUND: In acute lung injury (ALI), angiotensin II (Ang II) plays a vital role in the stimulation of pulmonary permeability edema formation through the angiotensin type 1 (AT1) receptor. The effect of Ang II on alveolar fluid clearance (AFC) in ALI remains unknown. METHODS: Sprague Dawley rats were anesthetized and intratracheally injected with 1 mg⁄kg lipopolysaccharide (LPS), while control rats received saline. The AT1 receptor antagonist ZD7155 was injected intraperitoneally (10 mg⁄kg) 30 min before LPS administration. The lungs were isolated for AFC measurement, and alpha-epithelial sodium channel (ENaC) messenger RNA and protein expression were detected by reverse-transcription polymerase chain reaction and Western blot. RESULTS: LPS-induced ALI caused an increase in Ang II levels in plasma and lung tissue but a decrease in AFC. The time course of Ang II levels paralleled that of AFC. Pretreatment with ZD7155 prevented ALI-induced reduction of AFC. ZD7155 also reversed the ALI-induced reduction of beta-ENaC and gamma-ENaC levels, and further decreased alpha-ENaC levels. CONCLUSIONS: These findings suggest that endogenous Ang II inhibits AFC and dysregulates ENaC expression via AT1 receptors, which contribute to alveolar filling and pulmonary edema in LPS-induced ALI.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: